Byoung Chul Cho | Scholar Profiles and Rankings

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12) (journal article) Lee, Dong Ki \| Park, Sook Ryun \| Kim, Yeul Hong \| Lee, Yun-Gyoo \| Shin, Su-Jin \| Ahn, Beung-Chul \| Lee, Sung Sook \| Lim, Sun Min \| Kim, Hye Ryun \| Cho, Byoung Chul \| Hong, Min Hee OncoImmunology, volume 13, issue 1 (2024). 10.1080/2162402X.2024.2371563 Cite \| Source
Amivantamab plus capmatinib in advanced non-small cell lung cancer (NSCLC) harboring MET alterations: Recommended phase 2 combination dose and preliminary dose-escalation results from the phase 1/2 METalmark study. (journal article) Spira, Alexander I. \| Cho, Byoung Chul \| Kim, Tae Min \| Kim, Sang-We \| Xia, Bing \| Artis, Eunice \| Dobbs, Jessica \| Baudelet, Christine \| Baig, Mahadi \| Sendur, Mehmet Ali Nahit Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 8619-8619 (2024). 10.1200/JCO.2024.42.16_suppl.8619 Cite \| Source
Sacituzumab govitecan (SG) + pembrolizumab (pembro) in first-line (1L) metastatic non-small cell lung cancer (mNSCLC) with PD-L1 ≥ 50%: Cohort A of EVOKE-02. (journal article) Patel, Jyoti D. \| Cho, Byoung Chul \| Cobo, Manuel \| Reyes Cabanillas, Roxana \| Vicente, David \| Fuentes Pradera, Jose \| Garon, Edward B. \| Mok, Tony S. K. \| Cappuzzo, Federico \| Neal, Joel W. \| ... \| Reck, Martin Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 8592-8592 (2024). 10.1200/JCO.2024.42.16_suppl.8592 Cite \| Source
A first-in-human, phase 1/2a study of GI-102 (CD80-IL2v3) in patients with advanced or metastatic solid tumors: Initial results from dose escalation. (journal article) Lee, Jeeyun \| Cho, Byoung Chul \| Lee, Jae-Lyun \| Lee, Jung-Yun \| Ma, Wen Wee \| Adjei, Alex A \| Campian, Jian Li \| Zhao, Yujie \| Seetharam, Mahesh \| Shim, Byoung Yong \| ... \| Jang, Myoung Ho Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 2598-2598 (2024). 10.1200/JCO.2024.42.16_suppl.2598 Cited by (1) \| Cite \| Source
Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-TKI, in patients with 3rd generation EGFR-TKI resistance in EGFR mutated advanced/metastatic non-small cell lung cancer (NSCLC). (journal article) Lim, Sun Min \| Cho, Byoung Chul \| Han, Ji-Youn \| Kim, Sang-We \| Lee, Ki Hyeong \| Nagasaka, Misako \| Jo, Anna \| Seah, Ethan \| Kim, Choonok \| Reungwetwattana, Thanyanan Journal of Clinical Oncology, volume 42, issue 16_suppl, pages TPS8658-TPS8658 (2024). 10.1200/JCO.2024.42.16_suppl.TPS8658 Cite \| Source
Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103) (journal article) Garralda, Elena \| Oh, Do Youn \| Italiano, Antoine \| Bedard, Philippe L. \| Delord, Jean‐Pierre \| Calvo, Emiliano \| LoRusso, Patricia \| Wainberg, Zev \| Cervantes, Andres \| Rodriguez‐Vida, Alejo \| ... \| Wu, Benjamin The Journal of Clinical Pharmacology, volume 64, issue 5, pages 544-554 (2024). 10.1002/jcph.2397 Cited by (2) \| Cite \| Source
Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER study (journal article) Bauman, Julie E. \| Karam, Sana D. \| O'Brien, Cathy \| Mak, Gabriel \| Cho, Byoung Chul Head & Neck, volume 46, issue 5, pages 1152-1159 (2024). 10.1002/hed.27726 Cite \| Source
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC (journal article) Lee, Eun Ji \| Oh, Seung Yeon \| Lee, You Won \| Kim, Ju Young \| Kim, Min-Je \| Kim, Tae Ho \| Lee, Jii Bum \| Hong, Min Hee \| Lim, Sun Min \| Baum, Anke \| ... \| Cho, Byoung Chul Clinical Cancer Research, volume 30, issue 8, pages 1582-1594 (2024). 10.1158/1078-0432.CCR-23-2951 Cite \| Source
Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types (journal article) Kim, Dong Kwon \| Lee, Chai Young \| Han, Yu Jin \| Park, So Young \| Han, Heekyung \| Na, Kwangmin \| Kim, Mi Hyun \| Yang, Seung Min \| Baek, Sujeong \| Kim, Youngtaek \| ... \| Pyo, Kyoung-Ho Frontiers in Immunology, volume 15 (2024). 10.3389/fimmu.2024.1330228 Cite \| Source
Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck (journal article) Sanz-Garcia, Enrique \| Zou, Jinfeng \| Avery, Lisa \| Spreafico, Anna \| Waldron, John \| Goldstein, David \| Hansen, Aaron \| Cho, B. C. John \| de Almeida, John \| Hope, Andrew \| ... \| Siu, Lillian L. Cell Death & Differentiation, volume 31, issue 4, pages 460-468 (2024). 10.1038/s41418-024-01272-y Cite \| Source
Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study (journal article) Lee, Jiyun \| Ahn, Hee Kyung \| Kim, Sang‐We \| Han, Ji‐Youn \| Lee, Sung Sook \| Park, Hyung Soon \| Lee, Hyun Woo \| Kim, Joo‐Hang \| Cho, Eunhan \| Huggenberger, Reto \| Cho, Byoung Chul Cancer Medicine, volume 13, issue 7 (2024). 10.1002/cam4.7174 Cite \| Source
Chemotherapy and Osimertinib Combination Should Not Be the First-Line Treatment for All Advanced EGFR+ NSCLC (journal article) Lim, Sun Min \| Lee, Jii Bum \| Cho, Byoung Chul Journal of Thoracic Oncology, volume 19, issue 3, pages 376-379 (2024). 10.1016/j.jtho.2023.12.007 Cited by (2) \| Cite \| Source
Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC (journal article) Vansteenkiste, Johan F. \| Naidoo, Jarushka \| Faivre-Finn, Corinne \| Özgüroğlu, Mustafa \| Villegas, Augusto \| Daniel, Davey \| Murakami, Shuji \| Hui, Rina \| Lee, Ki Hyeong \| Cho, Byoung Chul \| ... \| Antonia, Scott J. JTO Clinical and Research Reports, volume 5, issue 3, pages 100638- (2024). 10.1016/j.jtocrr.2024.100638 Cite \| Source
Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing (journal article) Lee, Seul \| Joo, Yunjoo \| Lee, Eun Ji \| Byeon, Youngseon \| Kim, Jae-Hwan \| Pyo, Kyoung-Ho \| Kim, Young Seob \| Lim, Sun Min \| Kilbride, Peter \| Iyer, Rohin K. \| ... \| Cho, Byoung Chul PLOS ONE, volume 19, issue 2, pages e0294857- (2024). 10.1371/journal.pone.0294857 Cited by (1) \| Cite \| Source
Successful Rechallenge of Trastuzumab Deruxtecan After Drug-Induced Interstitial Lung Disease in a NSCLC With HER2 Mutation: A Case Report (journal article) Nam, Sangho \| Lim, Sun Min \| Cho, Byoung Chul \| Lee, Jii Bum JTO Clinical and Research Reports, volume 5, issue 2, pages 100628- (2024). 10.1016/j.jtocrr.2023.100628 Cite \| Source
A phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced ccRCC. (journal article) Kim, Miso \| McDermott, Raymond S. \| Williamson, Stephen K. \| Cho, Byoung Chul \| Dowlati, Afshin \| Lakhani, Nehal J. \| Malhotra, Jyoti \| Kaczmar, John M. \| Papadopoulos, Kyriakos P. \| Safran, Howard \| ... \| Lewis, Karl Journal of Clinical Oncology, volume 42, issue 4_suppl, pages 434-434 (2024). 10.1200/JCO.2024.42.4_suppl.434 Cite \| Source
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer (journal article) Cho, Byoung Chul \| Chiu, Chao-Hua \| Massarelli, Erminia \| Buchschacher, Gary L. \| Goto, Koichi \| Overbeck, Tobias R. \| Loong, Herbert H.F. \| Chee, Cheng E. \| Garrido, Pilar \| Dong, Xiaorong \| ... \| John, Thomas Lung Cancer, volume 188 (2024). 10.1016/j.lungcan.2023.107442 Cited by (3) \| Cite \| Source
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial (journal article) Garon, Edward B. \| Lu, Shun \| Goto, Yasushi \| De Marchi, Pedro \| Paz-Ares, Luis \| Spigel, David R. \| Thomas, Michael \| Yang, James Chih-Hsin \| Ardizzoni, Andrea \| Barlesi, Fabrice \| ... \| Cho, Byoung Chul Journal of Clinical Oncology, volume 42, issue 2, pages 180-191 (2024). 10.1200/JCO.23.00910 Cited by (6) \| Cite \| Source
Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-cell lung cancer (journal article) Choi, Su-Jin \| Lee, Jii Bum \| Kim, Jae Hwan \| Hong, Min Hee \| Cho, Byoung Chul \| Lim, Sun Min Therapeutic Advances in Medical Oncology, volume 16 (2024). 10.1177/17588359241240657 Cite \| Source
Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-Pacific (journal article) Guo, Ye \| Nakashima, Torahiko \| Cho, Byoung Chul \| Lim, Darren W.-T. \| Yang, Muh-Hwa \| Lou, Pei-Jen \| Corry, June \| Lin, Jin Ching \| Zhu, Guo Pei \| Kim, Kyung Hwan \| ... \| Porceddu, Sandro Oral Oncology, volume 148 (2024). 10.1016/j.oraloncology.2023.106657 Cite \| Source